無料プレビュー

Organon & Co. (OGN) · New York Stock Exchange

プロフィール

Organon & Co. is a global healthcare company delivering medicines and solutions across women's health and general medicines in over 140 countries. The company's portfolio spans contraceptive and fertility products, biosimilars in immunology and oncology, and established brands in cardiovascular, respiratory, dermatology and pain management. Organon sells through drug wholesalers, retailers, hospitals, government agencies and managed healthcare providers, and operates six owned manufacturing facilities globally.

主要指標

株価: $13.75 (-0.29%)
時価総額: 36億ドル
PER（今期予想）: 4.1
PBR: 3.6
配当利回り: 0.58%
52週レンジ: $5.69 – $13.80
業種: Healthcare / Drug Manufacturers - General
上場: New York Stock Exchange
構成銘柄: —

比較会社: LLY Eli Lilly and Company、JNJ Johnson & Johnson、ABBV AbbVie Inc.、MRK Merck & Co., Inc.、NVS Novartis AG、AZN AstraZeneca PLC、AMGN Amgen Inc.、GILD Gilead Sciences, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-09 · 更新: 2026-10-09